ServiziMenu principaleHome
You are here:  > Educational Opportunities > Future Events > Bringing research insights into clinical implementation
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Bringing research insights into clinical implementation

Not eligible for ESCO credits

10.10.2024  -  11.10.2024

Warsaw, Poland


Chairs:  Giovanni Apolone, Mef Nilbert, Simon Oberst
Host Chair: Iwona Lugowska


CCI4EU (Comprehensive Cancer Infrastructures for Europe) is a European project aiming to help Member States and Associated Countries improve or develop their existing or future Comprehensive Cancer Infrastructures (CCIs), by helping develop their research & innovation-related capacities.

The CCI4EU project will run over 3 years. It has already defined and created a Maturity Model with quality indicators, to map the status of CCIs throughout the EU and potentially in five Associated Countries. Up to 9 sites will be selected for Deep Dive interventions, with 3 onsite visits to help them build their capacity in particular domains. Along with this, tailored online courses, resources and conferences will be developed to open up the capacity building to a wider audience, with the overall aim of contributing to the Horizon Europe Mission of ensuring that 90% of eligible cancer patients have access to Comprehensive Cancer Infrastructures by 2030.

This Conference, is the first of three that will be held over the course of the project. It will give individuals and teams from developing CCIs direction in helping them build their capacity and develop their infrastructures. The conference is intended to widen the participation of this EU grant to all Member States. The topic of this first conference is: Bringing research insights into clinical implementation.

The gap between research findings and clinical implementation poses a significant challenge in healthcare. Bridging this gap is essential to ensure that the latest evidence is incorporated into patient care effectively. This conference is aimed at professionals involved in translational research, clinical trialists, directors of science and hospital leaders.

Learning Objectives
  • Understand the importance of capacity building in research and innovation.
  • Learn how to develop a research programme.
  • Identify the ways to bring research findings into clinical settings.
  • Enhance collaboration between the Stakeholders and other research centres.
  • Explore real-world case studies and examples of successful/unsuccessful and ongoing research.


This conference is part of the CCI4EU project funded by the European Union



Dowload the Conference leaflet here.

Conference Structure

The conference will be a combination of lectures by international experts, discussions and breakout sessions.

During the breakout sessions some selected participants will be given the opportunity to present case studies of their own experience in research and clinical implementation (success stories, trials that didn’t work, trials that are ongoing with issues that need to be resolved).
The faculty and participants will discuss these cases studies in small groups.

Participant’s profile

As this is an EU funded project, the conference is open to anyone coming from EU Member States and the following associated countries: Albania, Georgia, Moldova, Ukraine and Norway.

Priority will be given to delegates from CCIs with a lower maturity according to the Maturity Model Mapping. Priority will also be given to multidisciplinary teams from such CCIs, not isolated individuals. In particular we are looking for:

  • People involved in translational research
  • Clinical trialists
  • Directors of science
  • People involved in innovation or technology transfer
  • Comprehensive Cancer Hospital leaders
  • People involved in precision cancer medicine and molecular tumour boards
  • People dealing with complex data issues for translational research
  • People involved with secondary cancer prevention

Attendance to the conference is on application basis, 100 participants will be selected to attend.
All participants will have their flights and up to 2-night accommodation organized and paid for by the project.

Fluency in English is required.


The conference will be held at: Maria Skłodowska-Curie Institute of Oncology.
It will begin at 08:30 on 10 October 2024 and end at 12:30 on 11 October 2024.

Accommodation and Travel

2 night’s accommodation (9 and 10 October) at Novotel Warszawa Centrum will be organized for all selected participants.
Flights to and from the conference will be organized by the conference travel agency.
Extra accommodation and accompanying guest will not be covered or organised by the project, nor will extra travel costs such as taxi, car park, refreshments, etc.


The course will be held in English and translation will not be provided.


The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.

Organising Secretariat

Sonia Bulgarelli
Email: sbulgarelli@eso.net
+39 3371061207

Francesca Marangoni
Email: fmarangoni@eso.net
+39 3663434699

Corinne Hall
Email: chall@eso.net
+39 3316125784



Attendance to the conference is on application basis, 100 participants will be selected to attend. Interested candidates should apply online providing the following:

  • CV & list of publications;
  • Motivation letter (if you are applying as a member of a team, please state this here together with the names of your colleagues);
  • Completed template for the Research and Innovation Case Studies (download the template here)

Priority will be given to delegates from CCIs with a lower maturity according to the Maturity Model Mapping. Priority will also be given to multidisciplinary teams from such CCIs, not isolated individuals.

Research and Innovation Case Studies

Please complete the template giving an example of research and innovation you have worked on: it could be a study that worked and was a success, something that didn’t work or that is ongoing with issues that need to be resolved. All applicants will have to submit a case, but people from the same team can upload the same case that will be presented by them together, if selected.

Some selected participants will have the opportunity to present their example in the format of a slide presentation (max. 10) to the participants and faculty members during the breakout sessions (as mentioned in the programme). Please don’t submit presentations at this stage in the application process.

Case studies from teams will also be accepted and the whole participating team should be mentioned in the template.


Successful applicants are granted:

- free registration, up to 2-night accommodation and meals as stated in the programme, flights to and from the location (booked by the provided agency).



10 October

8:30Welcome and introduction
Chairs: Giovanni Apolone, IT - Iwona Lugowska, PL - Mef Nilbert, SE - Simon Oberst, BE
8:40What is capacity building in research and innovation?
Simon Oberst, BE
9:20What are the main pathways to bring research insights into clinical practice
Mef Nilbert, SE
9:50Coffee break + Networking
10:30Research and innovation in the diagnostic pathway
Kjetil Taskén, NO
 10:50AI example in Poland
Jan Poleszczuk, PL
11:20Next generation design of clinical trials
Ulrik Lassen, DK
 11:40Next generation of secondary prevention
Ugo Pastorino, IT
12:10Federated Data Hubs
 12:30Exemplar: the work of Digicore
Gennaro Ciliberto, IT
14:00Breakout session 1 (4 groups)
16:00Coffee break + Networking
16:30Breakout session 2 (4 groups)
18:30End of Day 1
19:30Networking dinner

11 October

8:30Molecular diagnostics in practice
Maud Kamal, FR
 8:50How to organise molecular tumour boards
Susana Aguilar, ES
9:20Research and innovation in radiation oncology
 9:40Leading examples of radiotherapy clinical trials
Cai Grau, DK
10:10Coffee break + Networking
10:40How to develop a research programme in central/eastern Europe
Peter Nagy, HU
 11:00Example from a central European country (Latvia)
Piotr Rutkowski, PL
11:30How to collaborate with other research centres
 11:50The example of Alleanza Contro il Cancro
Paolo De Paoli, IT
12:20Closing remarks
Giovanni Apolone, IT - Iwona Lugowska, PL - Mef Nilbert, SE - Simon Oberst, BE


Susana Aguilar, Vall d' Hebron Institute of Oncology (VHIO), Vhioteca Dpt., Barcelona, ES
Giovanni Apolone, IRCCS National Cancer Institute, Scientific Direction, Milan, IT
Gennaro Ciliberto, IFO, Scientific Manager Department, Roma, IT
Paolo De Paoli, Centro di Riferimento Oncologico/Istituto, Alleanza Contro il Cancro, Aviano, IT
Cai Grau, Aarhus University Hospital, Dept of Oncology, Aarhus C, DK
Maud Kamal, Gustave Roussy Hospital, Scientific Manager Department, Villejuif, FR
Ulrik Lassen, Finsen Center-Rigshospitalet, Dept. of Oncology 5074, Copenhagen, DK
Iwona Lugowska, MSC Nationa Research Institute of Oncology, Early Phase Clinical Trials Unit, Warsaw, PL
Peter Nagy, Uszoki Utcai Hospital, Dept. of Surgery, Budapest, HU
Mef Nilbert, Lund University, Dept. Oncology, Institute for Clinical Sciences, Lund, SE
Simon Oberst, Organisation of European Cancer Institutes, Quality and Accreditation, Brussels, BE
Ugo Pastorino, Fondazione IRCCS, Istituto Nazionale dei Tumori, Chirurgia Toracica, Milano, IT
Jan Poleszczuk, CliniNote Hospital, Technology Officer Dpt., Warsaw, PL
Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Dept. of Soft Tissue/Bone & Melanoma, Warszawa, PL
Kjetil Taskén, Norwegian Radium Hospital, Research Building, Oslo, NO